Study at a glance
How were vitamin D signals and the skin barrier studied in animals?
Mouse and rat experiments tested different parts of skin-barrier function. One applied calcitriol, the active vitamin D hormone, to male mice with dermatitis, or skin inflammation, for four days. Another compared rats with no vitamin D receptor, rats with a receptor that bound vitamin D much less effectively, and normal rats.
Did active vitamin D applied to mouse skin improve the barrier?
The main treatment applied to the skin reduced water loss through the skin on later treatment days, improved dermatitis scores and restricted movement of a test substance within the skin. The method used to bring on dermatitis continued during treatment. Some defence and inflammatory signals changed, but others did not. A lower dose did not show the same benefit, and normal skin did not respond in the same way.
What happened when rats lacked a normal vitamin D receptor?
Rats without the receptor developed abnormal skin and hair. Rats retaining the altered receptor preserved several features but were not identical to normal rats. The water-loss difference between normal rats and rats without the receptor was clear only at 30 weeks among the ages examined. Some barrier-related genes were more active despite a poorer barrier, showing that gene activity cannot substitute for a test of how well the barrier worked.
Do these animal findings establish an eczema treatment for people?
Small samples, short treatment and reporting problems limit the mouse findings. The genetic changes affected the whole rat, so other body changes could influence the skin results. Separate human wound experiments examined local signals, not the same barrier treatment. These studies do not establish that oral vitamin D treats eczema, prevents skin infection or speeds wound healing.
Read the full article below ↓Mouse and rat studies examined different parts of skin-barrier biology: topical active vitamin D in established dermatitis, and genetic alteration of VDR. Their results connect functional permeability measurements with keratinocyte maintenance, without establishing a human supplementation benefit. The full appraisal is Vitamin D, Skin Barrier Function and Keratinocyte Maintenance: Full Evidence Review.
Topical calcitriol changed selected dermatitis endpoints
Umehara and colleagues treated male NC/Nga mice for four days while the dermatitis challenge continued. The principal calcitriol regimen reduced water loss on later treatment days, improved dermatitis scores and better restricted a dermally applied tracer below the upper epidermis. These are distinct observations about Vitamin D and Barrier Immunity.
Immune responses were selective: Defb1 and Defb2 increased, while Camp was not induced; Il13 and Il33 decreased without an equivalent Il4 response. A lower-dose comparison did not show the same benefit, and normal skin did not respond identically. Small groups, short duration and an inconsistency in the printed primer table limit stronger mechanistic or safety claims.
Receptor loss and impaired ligand binding differed
Kise and colleagues compared wild-type rats, VDR-knockout rats and rats retaining a receptor with greatly reduced ligand binding. Knockout animals developed disrupted skin and hair phenotypes; the knock-in animals preserved several features but were not identical to wild type. The reported water-loss difference between wild type and knockout was significant only at thirty weeks among the examined ages.
Whole-skin RNA sequencing showed increased expression of some epidermal barrier-associated genes despite the poorer knockout barrier. Expression is therefore not a substitute for function. These whole-body models also retain systemic confounding; supplementary proteomics compared one female wild-type rat with one female knockout rat and was exploratory. The findings connect Vitamin D Receptors with Vitamin D and Cell Differentiation without quantifying the complete epidermal turnover cycle.
Conclusion
A separate human wound-signalling study supports local activation and selected antimicrobial responses. It should not be treated as a repeat of the mouse permeability experiments. The combined evidence concerns specific barrier, immune and maintenance mechanisms; it does not establish that oral vitamin D treats eczema, prevents skin infection or accelerates wound healing.
Sources and publication details
Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice. Umehara Y and colleagues. International Journal of Molecular Sciences. 2023;24(11):9347. DOI: 10.3390/ijms24119347. PMID: 37298299.
Ligand-Independent Vitamin D Receptor Actions Essential for Keratinocyte Homeostasis in the Skin. Kise S and colleagues. International Journal of Molecular Sciences. 2025;26(1):422. DOI: 10.3390/ijms26010422. PMID: 39796272.
Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. Schauber J and colleagues. Journal of Clinical Investigation. 2007;117:803 to 811. DOI: 10.1172/JCI30142. PMID: 17290304.
Related reading
Management of Harlequin Ichthyosis: A Brief Review of the Recent Literature
The purpose of the present narrative review is to assess the most recent literature regarding the management of HI.
Original paper ↗Read more →Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice
Here, we investigated the effects of calcitriol, an active form of vitamin D3, on an NC/Nga mouse model of atopic dermatitis.
Original paper ↗Read more →Ligand-Independent Vitamin D Receptor Actions Essential for Keratinocyte Homeostasis in the Skin
Since Vdr-KO rats also showed abnormalities in the skin, the relationship between alopecia and skin abnormalities was examined.
Original paper ↗Read more →Vitamin D, Skin Barrier Function and Keratinocyte Maintenance: Full Evidence Review
Review mouse calcitriol and rat receptor experiments on skin permeability, immune markers and keratinocyte maintenance, with limits on clinical claims.
Read more →Vitamin D and Epithelial Barrier Failure Across Gut, Lung and Skin: Full Evidence Review
Gut, lung and skin studies compared: what vitamin D signalling reveals about barrier failure, and what human trials do and do not establish.
Read more →Vitamin D and Epithelial Barrier Failure Across Gut, Lung and Skin: Study Summary
Compare gut, lung and skin barrier findings in plain English, including differences between experimental models and human supplement trials.
Read more →Non-Skeletal Roles of Vitamin D in Skin, Gut, and Cardiovascular Disease: Focus on Epithelial Barrier Function and Immune Regulation in Chronic Disease
Vitamin D is increasingly recognized as a key regulator of epithelial barrier integrity and mucosal immune homeostasis, with implications extending far beyond skeletal health.
Original paper ↗Read more →Differential Expression of Proteins Involved in Skin Barrier Maintenance and Vitamin D Metabolism in Atopic Dermatitis: A Cross-Sectional, Exploratory Study
Using an intra-patient design, this study compared protein expression in intra-lesional (IL) and peri-lesional (PL) skin biopsies from AD patients and examined associations between protein levels, vitamin D status, and clinical features.
Original paper ↗Read more →Intestinal VDR, Barrier Function and Microbial Metabolism: Full Evidence Review
Examine vitamin D receptor experiments on intestinal barriers and microbial metabolism, alongside human trials of permeability, immune markers and microbiota.
Read more →Intestinal VDR, Barrier Function and Microbial Metabolism: Study Summary
Summary of intestinal VDR, Notch-related barrier responses and microbial metabolism, with direct human permeability and microbiota trial findings.
Read more →Calcitriol modifies tight junctions, improves barrier function, and reduces TNF‐α‐induced barrier leak in the human lung‐derived epithelial cell culture model, 16HBE 14o‐
Both effects were concentration dependent and active out to 168 h post‐treatment.
Original paper ↗Read more →Per: and Polyfluoroalkyl Substance-Induced Skin Barrier Disruption and the Potential Role of Calcitriol in Atopic Dermatitis
This study aimed to evaluate the effects of perfluorononanoic acid (PFNA) and perfluorooctanoic acid (PFOA), two widely detected PFASs, on epidermal function and gene expression in Human Epithelial Keratinocyte, neonatal (HEKn).
Original paper ↗Read more →CD1a promotes systemic manifestations of skin inflammation
Inflammatory skin conditions are increasingly recognised as being associated with systemic inflammation.
Original paper ↗Read more →Effects of calcitriol (1, 25-dihydroxy-vitamin D3) on the inflammatory response induced by H9N2 influenza virus infection in human lung A549 epithelial cells and in mice
Culture supernatants were collected every 24 h post infection and the viral growth kinetics and inflammatory response were evaluated.
Original paper ↗Read more →Vitamin D Receptor Regulates Liver Regeneration After Partial Hepatectomy in Male Mice
Vitamin D signals through the vitamin D receptor (VDR) to induce its end-organ effects.
Original paper ↗Read more →1α, 25-Dihydroxyvitamin D3 and the vitamin D receptor regulates ΔNp63α levels and keratinocyte proliferation
1α, 25-dihydroxyvitamin D3 (VD3), a secosteriod that has been explored as an anti-cancer agent, was also shown to promote cell survival.
Original paper ↗Read more →Sericin coated thin polymeric films reduce keratinocyte proliferation via the mTOR pathway and epidermal inflammation through IL17 signaling in psoriasis rat model
Therapeutic treatment forms can play significant roles in resolving psoriatic plaques or promoting wound repair in psoriatic skin.
Original paper ↗Read more →Vitamin D strengthens the bladder epithelial barrier by inducing tight junction proteins during E. coli urinary tract infection
Tight junction proteins are pivotal to prevent bacterial invasion of the epithelial barrier.
Original paper ↗Read more →1,25-Dihydroxyvitamin D Enhances the Regenerative Function of Lgr5+ Intestinal Stem Cells In Vitro and In Vivo
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder in the intestines without a cure.
Original paper ↗Read more →Characterization of Rickets Type II Model Rats to Reveal Functions of Vitamin D and Vitamin D Receptor
GM rats exhibited markedly elevated plasma parathyroid hormone and 1,25D3 levels compared to those of WT rats.
Original paper ↗Read more →Vitamin D Prevents Hypoxia/Reoxygenation-Induced Blood-Brain Barrier Disruption via Vitamin D Receptor-Mediated NF-kB Signaling Pathways
Maintaining blood-brain barrier integrity and minimizing neuronal injury are critical components of any therapeutic intervention following ischemic stroke.
Original paper ↗Read more →Original sources
Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice
Here, we investigated the effects of calcitriol, an active form of vitamin D3, on an NC/Nga mouse model of atopic dermatitis.
Publication details
Calcitriol, an Active Form of Vitamin D3, Mitigates Skin Barrier Dysfunction in Atopic Dermatitis NC/Nga Mice. Umehara Y and colleagues. International Journal of Molecular Sciences. 2023;24(11):9347. DOI: 10.3390/ijms24119347. PMID: 37298299.
Ligand-Independent Vitamin D Receptor Actions Essential for Keratinocyte Homeostasis in the Skin
Since Vdr-KO rats also showed abnormalities in the skin, the relationship between alopecia and skin abnormalities was examined.
Publication details
Ligand-Independent Vitamin D Receptor Actions Essential for Keratinocyte Homeostasis in the Skin. Kise S and colleagues. International Journal of Molecular Sciences. 2025;26(1):422. DOI: 10.3390/ijms26010422. PMID: 39796272.
Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism
Published in Schauber J and colleagues. Journal of Clinical Investigation (2007).
Publication details
Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. Schauber J and colleagues. Journal of Clinical Investigation. 2007;117:803 to 811. DOI: 10.1172/JCI30142. PMID: 17290304.